Apollo Hospitals Enterprise LtdQ4 FY26
Apollo Hospitals Enterprise Ltd Q4 FY26 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Price: ₹8,714P/E: 59.4Market Cap: ₹1.2L CrSector: Healthcare Services
Management growth scorecard
Revenue
Category 2
Margin
Category 2
Fundraise
N/A
Order
N/A
Capex
Yes
1 of 3 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
Category 2- →Apollo HealthCo aims for INR 25,000 crore revenue run rate by Q4 FY27, growing from INR 19,000 crore pro forma basis in FY26, targeting 21% growth.
- →30% growth currently driven by top 5 markets; expansion planned into new markets.
- →Pharmacy business acquiring 200,000-220,000 new customers monthly, expected to increase with 7,500 outlets synergy.
- →Diagnostics business growing 25%-30%, with plans to further grow and strengthen through integration.
- →Hospital services targeting mid-teen revenue growth in FY27; expecting gradual revenue acceleration and better asset utilization.
- →New hospitals adding about 1,400 beds, with phased commissioning; 500-600 beds expected operational by mid-FY27.
- →Apollo 24/7 digital platform expected to break even soon, driving margin improvement in integrated business.
- →Focus on sustainable, calibrated growth with improving unit economics across segments.
Margin guidance
Category 2- →Company expects overall Healthcare Services to deliver mid-teen revenue growth in FY27 with improved margins by at least 100 bps in established units.
- →Hospitals business EBITDA loss anticipated around INR 150 crore for FY27, with peak losses in Q4 due to new hospital ramps.
- →Apollo HealthCo (AHLL) aims for INR 25,000 crore run-rate revenue by Q4 FY27, growing at about 21% annually with EBITDA margin guidance of 6.5% to 7%.
- →Digital business projected to break even including ESOP costs by Q3 FY27, contributing positively to EBITDA.
- →Established hospitals expected to continue margin expansion beyond current ~25.5% through asset utilization and cost optimization.
- →Grew 19.5% in FY26, projecting 21% growth next year sustained by private label and digital cost reductions, driving margin improvement.
- →Capacity expansions planned with 1,400 new hospital beds to be operational by FY28, aiding revenue growth and hospital business breakeven.
3 more insights locked — sign up free to unlock
Fundraise plans
- →No explicit mention of any new fundraising through debt or equity during the call.
- →The company paid off INR 1,250 crore to buy out IFC this quarter from the Healthcare Services balance sheet.
- →Capex for growth continues with INR 1,550 crore re-deployable for growth capex, expected to continue similarly in the coming year.
- →The company plans to sustain growth capex without significantly increasing this number next year.
- →Focus remains on internal cash flow generation and operational cash flow, with operating cash flow before dividends of around INR 1,850 crore in FY26.
- →No announcements or indications of fresh fundraising through new debt or equity in the near term, rather focus on efficient capex deployment and service expansion.
Order book
The transcript does not explicitly provide information about current or expected orderbook or pending orders for Apollo Hospitals Limited or its subsidiaries. The discussion primarily focuses on business performance, expansion plans, hospital bed additions, digital platforms, and legal matters related to Indraprastha Medical. No specific mention of orderbook or pending orders was made in the provided pages.
Capex plans
Yes- →Growth capex for hospitals is expected to continue at around INR 550 crore annually, considered fully redeployable for expansion.
- →INR 1,980 crore capex is planned for FY27 to commission 1,000 new beds.
- →Four new hospitals operationalized in FY26 with 855 beds capacity; 185 beds operationalized, remaining 670 beds to be commissioned over next 12 months.
- →Two more hospitals (Sarjapur and Gurugram) expected to be commissioned in the next two quarters, adding up to approximately 1,400 beds in metro markets by FY28.
- →Investments ongoing in clinical leadership (oncology, robotics, advanced care), technology, and digital health to improve consumer engagement and operational integration.
- →Apollo HealthCo continuing investment in digital tech and insurance with quarterly ESOP costs around INR 50 crore expected to taper.
- →Combined efforts focus on sustainable long-term growth, integrating the Apollo ecosystem across physical and digital platforms.
How does Apollo Hospitals Enterprise Ltd rank vs peers in Healthcare Services?
Pro feature1Apollo Hospitals Enterprise Ltd
Rev 2Mar 2
See full Healthcare Services sector rankings
How does Apollo Hospitals Enterprise Ltd rank in Healthcare Services?
Compare Apollo Hospitals Enterprise Ltd against every Healthcare Services company (Q4 FY26) on revenue, margins and earnings-call signals.